Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Abbvie Inc. (ABBV) Dividend Stock Analysis

|Includes: AbbVie Inc. (ABBV), BMY, LLY, MRK

Linked here is a detailed quantitative analysis of Abbvie Inc. (NYSE:ABBV). Below are some highlights from the above linked analysis:

Company Description: Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis.

Continue Reading »